Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-01

Clinical Trial Update: Feasibility Study of Take-Home LAAM Medication - 3 [Phase 4]

View source ↗

Summary

A Phase 4 feasibility trial testing take-home LAAM for opioid-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAAM (Methadyl acetate)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Opioid-Related Disorders | Phase 4 | Status: COMPLETED